Mechanistically, NR3C1‐mediated transcriptional regulation of the IL6‐AS1 promoter drives COPD susceptibility through inflammatory pathway activation, positioning NR3C1 as a central epigenetic regulator of IL6‐AS1‐driven disease progression. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.